EMED TELEHEALTH KIT
DEAD

Serial Number

97585928

Owner

EMED, LLC

Attorney

Thomas Y. Yee

Filing Date

Sep 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EMED TELEHEALTH KIT Trademark

Serial Number: 97585928

EMED TELEHEALTH KIT is a trademark filed by EMED, LLC on September 9, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

EMED, LLC (81 trademarks)

Miami, FL 33132

Entity Type: 16

Trademark Details

Filing Date

September 9, 2022

Registration Date

Not Registered

Goods & Services

Audio teleconferencing; Instant messaging services; Network conferencing services; Teleconferencing services; Video conferencing services; Video teleconferencing

Diagnostic preparations for medical purposes; medical diagnostic rapid test kits comprised of chemical reagents, solvents, swabs, vials, and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; diagnostic media for cultures for use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; rapid test kits for medical purposes comprised of chemical reagents, solvents, swabs, vials and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants

Rapid test kits for scientific and research use comprised of chemical reagents, solvents, swabs, vials, and containers for safely storing tests for analysis and use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants; media for cultures for scientific and research use in detecting, screening, and monitoring the presence of microorganisms, infectious agents, viruses, diseases, antibodies, antigens, receptors and contaminants

Prescription drug release verification services being verification of personal identity as part of personal background analysis of courier service providers; verification of personal identity as part of personal background analysis

Telemedicine services, namely, providing remote proctoring of diagnostic tests; providing digital educational health information relating to disease

Identity verification services, namely, providing electronic verification of on-line test results and generating electronic permission codes which then allow users to access said digital content; providing user authentication of personal identifying information via secure storage and transmission of supporting evidence via the internet for online software applications; providing user authentication of personal identifying information via video conference for online software applications; providing document verification services, namely, providing remote identity document scanning being electronic scanning of personally identifying photographic images, photo scanning, digitization of documents, data extraction being data encryption, data decryption; providing prescription drug release user authentication services via secure storage and transmission of supporting evidence via the internet for online software applications; providing user authentication services for using software technology for personal identity verification for telemedicine

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 17, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 17, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 25, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 25, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 25, 2023 GNFN
FINAL REFUSAL E-MAILED
Sep 25, 2023 GNFR
FINAL REFUSAL WRITTEN
Sep 25, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 2, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 10, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 10, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 10, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 10, 2023 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2022 NWOS
NEW APPLICATION ENTERED
Sep 13, 2022 NWAP